Kymera inks deal with Gilead as partnership with Sanofi faces a switch-up
Gilead has enlisted Kymera Therapeutics to develop a compound that it hopes can be part of the next wave of targeted breast cancer treatments. The partnership, which was announced Wednesday, centers ...
Gilead has enlisted Kymera Therapeutics to develop a compound that it hopes can be part of the next wave of targeted breast cancer treatments.
The partnership, which was announced Wednesday, centers ...
